Caricamento...
Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer treatment in Japan can be easily available for outpa...
Salvato in:
| Pubblicato in: | Jpn Dent Sci Rev |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501734/ https://ncbi.nlm.nih.gov/pubmed/28725297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdsr.2016.11.001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|